stitial nephropathy that has many clinical and morphodisease (ADMCKD) is characterized by the development of logical features similar to juvenile nephronophthisis cysts at the corticomedullary border of the kidneys. It resembles (NPH; MIM 256100). The most striking differences benephronophthisis (NPH) with an autosomal-recessive mode of tween these entities are the age of onset of the disease inheritance. Genetic linkage has been shown either on chromoand the mode of inheritance, which is recessive in NPH. is usually diagnosed in the fourth decade of life [1] . HowMethods. The Finnish Transplantation Register and hospital ever, there are reports in which the patients have been records were searched to identify all of the ADMCKD families children, and ages at the end-stage renal disease (ESRD) in the Finnish population. Detailed clinical information of the vary between 5.5 and 64 years [2] [3] [4] [5] [6] . In other reports of patients was collected. Linkage analysis was used to study whether the Finnish families originating from a homogenous ADMCKD, patients have been adults, between 19 years population showed genetic linkage to the ADMCKD1 or and 78 years at end-stage renal failure [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Hyperten-ADMCKD2 loci. Also, the coding region of a strong candidate sion is the most common first symptom of the disease. gene, natriuretic peptide receptor A (NPRA), located on the The patients' urinary concentration ability is defective. chromosome 1q21 critical region, was sequenced using polyUrine analysis produces normal results. Renal failure is merase chain reaction sequencing with an ABI 377XL Automated DNA sequencer (Applera Corp., Norwalk, CT, USA).
progressive, and the condition has to be treated with dial- sign seen in ADMCKD as well as in juvenile NPH [18, 19] .
Conclusion. This study locates the gene for ADMCKD1
In recessively inherited NPH end-stage renal failure close to a marker D1S1595 in a region Ͻ5 cM, and further is reached around 10 years of age. The most common first confirms the existence of at least three loci for the medullary signs of the disease are anemia, growth retardation, polycystic kidney disease. Heterogeneity of the symptoms complicates the clinical diagnosis and classification of the patients. dipsia, and polyuria. The recessive and dominant forms Further studies are needed to identify the disease-causing gene.
cannot be differentiated from each other by renal biopsy or by examining the occurrence of renal cysts. The clearest difference between them is the mode of inheritance [1] .
Molecular genetic studies have already facilitated the beginning of classification of heterogeneous NPH and ADMCKD. The NPH locus was assigned by linkage lished: the first on chromosome 1q21 (ADMCKD1) to the critical region of 8 cM for two large Cypriot families  2001 by the International Society of Nephrology [25] and the second on chromosome 16p12 (ADMCKD2) study; those with occasional low-grade proteinuria, that is, below 0.3 g/L, were included. Special attention was to a critical region of 10.5 cM for one Italian family [6] .
paid to the occurrence of hyperuricemia and/or gout, In addition to progressive renal failure and hypertension, which were reported by Scolari et al and Stavrou et al hyperuricemia and gout were represented in both of [6, 17] . Serum urate levels were examined and/or patients these families. The existence of at least a third locus were asked whether they had experienced gout episodes was confirmed by Kroiss et al in five families without in the past. Blood pressure was measured and/or anahyperuricemia and gout [26] . Quite recently, Cohn et al lyzed through all available hospital records, especially reported the localization of the disease-causing gene to at the beginning and during the progression of renal failchromosome 1q21 in an Iraqi Jewish family whose memure. The minimum criteria for considering somebody bers have nephropathy and hypertension [9] . Familial affected were progressive renal failure based on elevated juvenile gouty nephropathy (FJGN; MIM 162000) is an serum creatinine value and/or early-onset hypertension autosomal-dominant disease characterized by juvenile under the age of 30 years. Four of these families have onset of hyperuricemia, gout, and progressive renal failbeen partially reported previously [1] . ure. In two out of three Czech families, a locus for FJGN Genealogical studies were performed, and the families was assigned to chromosome 16p11. 2 [27] . However, were traced back four to six generations in a search for none of the genes or their mutations that cause the precommon ancestors. viously mentioned disorders have been identified. One
Each family members' informed consent was obtained of the strong candidate genes in the 1q21 region is the before collecting their blood samples. NPRA gene encoding atrial natriuretic peptide (ANP) receptor A (MIM#108960).
Linkage analysis The purpose of this study was to examine the preva-DNA was extracted from the blood samples (10 mL) lence of ADMCKD in the isolated Finnish population according to a standard procedure modified to accommoand to investigate whether the two previously identified date Phase Lock Gel tubes (5Ј → 3Ј). Eleven microsatelgene loci on chromosomes 1q12 and 16p12 are responsilite markers were selected to cover the critical region of ble for ADMCKD in Finnish families. We found a total chromosome 1q21 and five markers to cover the chromoof six affected families, five of them with a genetic linkage some 16p12 region. Microsatellite polymorphic markers to chromosome 1. One family with ADMCKD and gout were obtained from the Genome Database (http://www. could not be assigned to chromosomes 1 nor 16. Furthergdb.org; Table 2 ). We also analyzed a polymorphic remore, we excluded the NPRA gene as a candidate gene peat residing in the promoter region of the NPRA gene for ADMCKD based on its involvement in the regulation [31] . An MJ Research programmable thermal cycler (MJ of blood pressure and extracellular fluid volume [28] [29] [30] .
Research, Watertown, MA, USA) was used to perform the polymerase chain reactions (PCRs). The fluorescentlabeled fragments were separated on an ABI 377XL auto-METHODS mated DNA sequencer (Applera Corp., Norwalk, CT, Patients USA) with Genescan version 2.1 software (Applera Corp). A nationwide search was made to find all possible paTwo-point linkage analyses were performed by the tients with ADMCKD in Finland. Two approaches were MLINK program of the LINKAGE package [32, 33] . used to reach as complete an ascertainment as possible.
The disease gene frequency was set to 10
Ϫ4
. Marker allele First, all renal transplantations in Finland are performed frequencies were calculated from analysis of the patient at Helsinki University Central Hospital starting in 1964.
material. The Finnish Kidney Transplantation Register (FKTR) was started at the same time, and their files and hospital Physical mapping records were evaluated. Second, a letter with a descripTo localize the NPRA gene in respect to the markers tion of NPH-ADMCKD and a request to report espestudied, the DNA of 11 YACs (643_h_5, 709_c_5, 734_d_9, cially early cases that could not be identified as FKTR 736_f_4, 742_f_6, 764_a_1, 776_e_9, 776_h_9, 890_e_4, was sent to nephrologists of five university and 16 central 950_e_2, and 995_e_1) localized to the 1q21 region was hospitals.
amplified by PCR. In addition, the genetic map of MarshAn autosomal-dominant inheritance pattern had to be field Genetic Research Foundation (http://research. seen in the families included in the study. A renal biopsy marshfieldclinic.org/genetics/Default.htm) was used. The specimen from at least one affected individual of each YACs were obtained from the CEPH YAC Library (Paris, family had to be available that showed the characteristic France). changes of tubulointerstitial nephritis, especially thickSequencing of the NPRA gene ening of the tubular basement membrane. The specific gravity of the patients' urine had to be lowered. Patients
The PCR amplification of the 22 exons forming the coding region of the NPRA gene was performed in two with hematuria or proteinuria were excluded from the affected individuals 3 and 23 and one healthy control Family 3. In this family, the ages of first symptoms and especially the ages at ESRD or death vary substantially, (individual 2) [34] . The PCR products were purified by treatment with 0.5 U shrimp alkaline phosphatase and from 34 to 55 years. Patient 4 reached end-stage renal failure at the age of 55 years. However, her brother 2.5 U exonuclease at 37ЊC for 25 minutes, followed by inactivation for 15 minutes at 80ЊC. The purified products (patient 5) has been an obligatory carrier and died of an unspecified lung disease at the age of 64 years without were sequenced directly using the ABI-PRISM dye terminator cycle sequencing ready reaction kit (Applera any symptoms or signs referring to ADMCKD. Family member 14 died accidentally at the age of 47 years. It Corp.) on an ABI 377 automatic sequencer. Sequencing results were compared with the reference human NPRA is reasonable to assume that he died before developing any symptoms of the kidney disease. sequence (GenBank accession numbers AF190631) by use of Sequencer 4.05 (GeneCodes). Both strands were 27 also has had difficult gout, and he is the only who has from the middle-eastern part of Finland, the so-called received a kidney transplant. Patients 25 and 26 do not late settlement area inhabited during the 16th century.
yet have signs of renal failure. They only have episodes Family 1. In this family, all of the patients were Յ30 of gout and hypertension, respectively. years when the first symptoms of the disease appeared.
Linkage analysis Intrafamilial variation of the age of ESRD or death was not remarkable and occurred between the ages of 25 Five of the six families (families 1 through 5) with and 33 years. The progression of the disease from the MCKD showed a linkage to chromosome 1q21 region first symptoms to ESRD was rapid, a maximum of eight (Fig. 1 ). Linkage to both chromosome 1q21 and 16p12 years. Anemia was the first observed symptom of the was excluded in family 6 (Fig. 2) . On chromosome 1 disease with three patients (6, 7, and 8) . None of the critical region, the best two-point LOD scores of 5.43 and patients had episodes of gout, and the serum urate values 2.31 were obtained for markers D1S1595 and D1S305 at of the three investigated patients were within the normal ϭ 0 ( Table 2) . Because of the low heterozygosity ratio limits. Hypertension was not seen within this family.
of markers NPRA and D1S2715 (0.48 and 0.57, respecFamily members 5 and 9 were not systematically studied, tively), the corresponding LOD scores of 0.85 and 1.09 but none of them had experienced anemia, elevated are lower than average in region of interest. Haplotype blood pressure, or any symptoms that might refer to analysis was performed in order to identify recombina-ADMCKD. They were 37 and 36 years of age, and all tion events. the patients of this family had reached ESRD or died In family 3, the affected siblings (31 and 30) shared under the age of 33 years. the same haplotype (Fig. 1) . Identical disease haplotype Family 2. In family 2, patients 10, 13, and 33 had 6-8-10-14-4-10-4-10-14-4-8 also was observed in family hypertension as their first symptom of the disease. Two 5, which led us to consider this haplotype to be an ancespatients have received kidney transplants, and the protral one. The affected cousin (patient 16) shared the disgression from the first elevated serum creatinine values ease haplotype between markers D1S1153 and D1S1679. Interestingly, part of the disease haplotype was observed to transplantation has been long, from nine to eleven years. Family member 11 is 60 years of age and has also in a healthy member (patient 40) at D1S2125, although due to the missing parental data and the uninforsuffered from hypertension for over 30 years, but her serum creatinine value is still within normal limits. She mativeness of the markers, the extent of sharing cannot be determined. In families 3, 4, and 5, a common haplotype lives abroad, and it has not been possible for her to participate in any detailed tests.
was observed between markers D1S2624 and D1S1595. Physical mapping and sequencing tween loci D1S1153 and D1S2624, to a region Ͻ5 cM. The highest two-point LOD score of 5.43 was detected The chromosome 1 markers were ordered on the basis with marker D1S1595 at a theta value of zero. Interestof our YAC analyses and the available genetic map inforingly, this D1S1595 also gave the highest LOD score in mation. Based on the PCR analysis of the 11 YAC clones the Cypriot families [25] , suggesting that the gene for located in the region, markers NPRA, D1S2715, D1S305, ADMCKD1 might lie very close to this marker. The and D1S2125 were located within the same clone, 950_e_2. localization of one candidate gene, NPRA, was estabHowever, their mutual order could not be identified.
lished by YAC analyses in the critical region (Fig. 2) . Markers D1S2721, D1S1153, D1S2624, and D1S1595
This receptor, located mainly in the kidney, vascular were not localized in any of the 11 YACs studied from tissue and adrenal gland, is involved in the signaling the region (data not shown). The coding region of the processing mediated by ANP. Mice with targeted disrup-NPRA gene consisting of 22 exons was sequenced and tion of NPRA showed hypertension, cardiac hypertrophy, excluded as a disease-causing gene for ADMCKD1. and sudden death [37] . We excluded a disease-causing mutation in ADMCKD1 in the coding region of this DISCUSSION functionally relevant candidate gene by sequencing the 22 coding exons. Genetic linkage of ADMCKD was first established to chromosome 1q21 [25] between marker loci D1S498 and Families 3 through 5 originate from the early settlement area of Finland and have partially the same haplo-D1S2125. We have identified a total of six families with ADMCKD in Finland, five of them showing linkage to type, suggesting that they might have the same mutation due to a founder affect. Families 1 and 2, originating from chromosome 1. Genetic heterogeneity was evident, as one of our families (family 6) was not linked to either the late settlement area of Finland, possess a different haplotype and might consequently carry a different muthe ADMCKD1 or ADMCKD2 gene loci (Fig. 2) . Based on our findings, the disease locus for ADMCKD1 was tation(s). When the clinical phenotype of the patients carrying the same haplotypes were compared, no clear further restricted because of a recombination event be- The results of the measurements of blood pressure, serum creatinine, urine-specific gravity and proteinuria at the time when the diagnostic evaluations started. Abbreviations are: ND, not determined; N, normal result; HT, hypertension (Ͼ150/90); prot, protein in the urine; ϩ, renal biopsy done, typical findings of ADMCKD; Ϫ, renal biopsy not done; not yet, end-stage renal disease (ESRD) not yet reached. Table 2 . Two-point LOD scores of the chromosome 1 region with hyperuricemia and gout has been reported [6, 25] .
for Families 1 to 5
These extrarenal symptoms were not prominent in our hyperuricemia, reduced fractional excretion of uric acid, and elevated serum creatinine kinase levels. Genetic heterogeneity was evident as a linkage to chromosome 16 correlation could be observed. Instead, prominent differwas excluded in one family. Also, in the Finnish family ences were identified especially in the age of the disease material the affected members in family 6 all had early onset and progression to end-stage renal failure.
onset gout, but linkage to ADMCKD1 and ADMCKD2 was excluded. In both ADMCKD1 and ADMCKD2, an association third locus exists for ADMCKD in the genome.
